La gota es la cristalización del ácido úrico, y está entre las formas de artritis más controlables. Un ataque se manifiesta como una articulación roja, caliente y de dolor insoportable que alcanza su punto máximo en un día o dos. Tres tratamientos lo calman rápido: un antiinflamatorio, colchicina a dosis baja o un ciclo corto de corticoides. Evitar que la gota vuelva a aparecer es una segunda tarea, más larga.
Para los ataques que siguen repitiéndose o las articulaciones que se dañan, un comprimido diario reductor de urato como el alopurinol disuelve los cristales y detiene los ataques. La dieta por sí sola rara vez lo consigue. La dieta sí baja el nivel: la cerveza, los licores y las bebidas azucaradas elevan el ácido úrico, mientras que perder el exceso de peso, los lácteos desnatados, el café, las cerezas y un plato de estilo DASH lo reducen. La magnitud de ese efecto es modesta, así que una vez que los ataques son frecuentes, la dieta actúa junto con el comprimido.
Practice Ranking
Every practice we track for Gout: Lowering the Uric Acid That Drives It, ranked by how well the evidence supports it for this condition. Strength describes the evidence, not our endorsement.
6 practices · 3 to start with
| # | Practice | Evidence | Type | Cost | Effort | Results In | Add to plan |
|---|---|---|---|---|---|---|---|
| 1 | Alcohol and Your Health: What the Evidence Shows Now Each daily beer raised the risk of new gout about half again, so cutting beer and spirits lowers it; wine showed no link. | Strong | Self-Directed | Free | Moderate to Hard | Weeks to Months | |
| 2 | Whole Foods and Ultra-Processed Foods: What the Evidence Shows and How to Eat Well Two or more sugary soft drinks a day nearly doubled gout risk and most meat or seafood raised it 40 to 50%, while purine-rich vegetables did not, so the change to make is sugary drinks and heavy meat. | Strong | Self-Directed | $ to $$ | Moderate to Hard | Weeks to Months | |
| 3 | Sodium Reduction & DASH Diet: What Lowers Blood Pressure, and How to Do It The DASH pattern lowered uric acid 0.35 mg/dL on average, and 1.29 in those starting highest, and eating closest to it meant about 32% lower gout risk. | Moderate | Self-Directed | Free to $ | Moderate | Days to Weeks | |
| 4 | Caffeine: What It Does, the One Catch for Sleep, and How to Use It Well Six or more coffees a day tracked with well under half the gout risk. | Moderate | Self-Directed | Free to $ | Easy | Days | |
| 5 | Weight Loss: The Single Strongest Lever for Metabolic Health, and What the Trials Actually Show Lowers urate and flare risk in people carrying extra weight. | Moderate | Self-Directed | Free to $$$ | Moderate to Hard | Weeks to Months | |
| 6 | Vitamin C: What It Actually Does, Colds, and the Right Dose The highest vitamin C intake tracked with about half the gout risk, and supplements lowered uric acid about 0.35 mg/dL, a modest add-on rather than a substitute for urate-lowering therapy in established gout. | Moderate | Supplement | $ | Easy | Days | |
Default order puts the best-supported practices first, with self-directed care ahead of clinical options. Click any row to open the practice.
What It Is
Gout is a disease of crystals. It begins with uric acid, a waste product the body makes when it breaks down purines, the building blocks found in the body's own cells and in food. Uric acid dissolves in the blood only up to about 6.8 mg/dL at body temperature. If it stays above that level long enough, it comes out of solution as sharp, needle-shaped urate crystals. Those crystals settle in a joint, most often the base of the big toe, where it is coolest.
An attack, or flare, is the joint reacting to those crystals: sudden red, hot, swollen, unbearable pain that comes on overnight. It peaks in a day or two and settles within a week or two, even without treatment. Because it settles on its own, many people get through a first flare without ever looking for the cause, and gout keeps returning.
The serum urate level, the amount of uric acid in the blood, is what drives everything else. When it stays high enough for long enough, crystals keep forming and attacks keep returning. Bring the level down and hold it down, and the crystals dissolve and the attacks stop. Gout usually moves through stages:
- A first flare is a single attack that then quietens.
- Recurrent gout is attacks that keep returning, in the same joint or new ones, with normal-feeling stretches between them. Each flare signals that the urate has been sitting high enough to seed more crystals.
- Chronic tophaceous gout is years of high urate leaving chalky deposits, called tophi, in and around joints, under the skin, and in the ear. These deposits can slowly damage the joint.
- A high level with no attack shows up on a blood test in someone who has never had a flare. Most people at this stage never develop gout. Guidelines do not start urate-lowering medication for a raised level with no attacks, the drinks and the weight are where the lever is.
Gout rarely occurs alone. High uric acid clusters with excess weight, high blood pressure, type 2 diabetes, high cholesterol and chronic kidney disease, the group often called metabolic syndrome. The same habits drive both those conditions and high urate, so they tend to travel together. The levers that lower gout risk, chiefly losing excess weight and a DASH-style plate, are the same ones that protect the heart and the kidneys. Managing gout well means treating the weight, blood pressure and blood sugar alongside the joint.
What Helps
Settling an attack and lowering uric acid over the long run are treated with different drugs; each does little for the other. Diet and lifestyle work for both, and lower the level on their own. Once attacks keep returning, a daily tablet is added to that base.
Settling an attack that is happening now
An acute flare is treated to calm the inflammation, and three options work about equally well:
- an anti-inflammatory painkiller such as naproxen
- low-dose colchicine
- a short course of an oral steroid such as prednisolone
Which one suits you depends on your kidneys and your other drugs. Starting early matters most. Low-dose colchicine, 1.8 mg over the first hour, started within the first 12 hours of a flare, eased pain in about 38% of people against 16% on a dummy pill. That low dose worked as well as the old high dose while causing far less diarrhea, 23% against 77%. Started late, any of these works less well, so agree a plan with your prescriber ahead of the next attack.
The diet and drink levers
Diet and drink changes lower the uric-acid level and cut risk, though each moves the number only a little. Once attacks are frequent, diet supports the tablet but rarely replaces it.
What you drink moves the level most:
- Beer and spirits. Each daily beer raised the risk of developing gout by about half, and spirits by less, while wine in moderation showed no link at all in the same large study.
- Sugary and high-fructose drinks. Two or more sugary soft drinks a day nearly doubled the risk, while diet drinks carried no such link. The fructose in the sweetened drink is what drives urate up, while the sugar in whole fruit leaves the level alone. That is a manufactured exposure, the same ultra-processed pattern behind the metabolic-syndrome cluster gout travels with.
- Coffee. People who drank six or more cups a day had well under half the gout risk of people who drank none. The effect showed up partly with decaf, so it is not caffeine alone.
- Low-fat dairy. Skim milk and yogurt are linked to about 44% lower risk and appear to help the kidneys pass urate.
- A DASH-style plate. A plate heavier on vegetables, fruit, whole grains and low-fat dairy and lighter on red meat and sugar lowered the level in a feeding trial. In a long-running study, people who ate this way had about 32% lower gout risk.
- Losing excess weight. This is the most powerful lever of all: a major weight loss takes roughly 1 to 3 mg/dL off the level and brings fewer attacks over time. It is the hardest lever to hold.
- Cherries and vitamin C. Each is linked to a small drop in risk or flares.
- Water. It helps the kidneys clear urate and lowers the risk of uric-acid kidney stones.
When attacks keep returning: the urate-lowering tablet
When attacks keep returning despite the diet and weight work, the crystals and the level behind them need direct treatment. That means a daily urate-lowering tablet, taken for the long term. For recurrent or tophaceous gout it is the one lever that reliably clears the crystals. Allopurinol is the usual first choice. In the one trial against a dummy pill, it brought 96% of people to their target uric-acid level, against none on placebo. Holding the level down dissolves the existing crystals over months and prevents new attacks. Guidelines set the target below 6 mg/dL for most people, and below 5 mg/dL when there are tophi to dissolve.
Two steps decide whether it works:
- Start low and raise slowly to reach the target, with an anti-inflammatory or colchicine alongside for the first months, because attacks can briefly increase as long-settled crystals begin to mobilize.
- Take it for the long term, usually for life, because the level climbs straight back when it stops.
People not warned of this often stop the tablet at the first flare and conclude it failed, when the early flare is the treatment starting to work.
Febuxostat is an alternative when allopurinol is not tolerated. One large trial found more cardiovascular and overall deaths on febuxostat than on allopurinol. A later trial found no such increase in deaths: part of why allopurinol is still the first choice.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Gout
Cada cerveza diaria elevó el riesgo de gota nueva aproximadamente la mitad más (RR 1.49); el vino no mostró vínculo
Cada cerveza diaria elevó el riesgo de desarrollar gota en aproximadamente la mitad y los licores algo menos, mientras que el vino no mostró vínculo; los bebedores intensos tuvieron aproximadamente dos veces y media el riesgo de los abstemios.
Cada porción diaria de 12 onzas de cerveza conllevó un riesgo relativo multivariable de gota nueva de 1.49 (IC del 95 %: 1.32 a 1.70), y cada porción diaria de licores 1.15 (1.04 a 1.28). El vino no mostró asociación (RR 1.04 por copa diaria; 0.88 a 1.22). En comparación con los abstemios, los hombres que bebían 50 g o más de alcohol al día tuvieron 2.53 veces el riesgo (1.73 a 3.70). Measured in: 47,150 men in the Health Professionals Follow-up Study with no history of gout at baseline, followed 12 years, with 730 incident cases. What could explain it instead: Heavy drinkers tend to weigh more, eat more meat, and differ in overall health behavior, all of which independently raise gout risk; residual confounding could inflate the alcohol association even after adjustment.. Se trata de una cohorte observacional, por lo que muestra asociación, no prueba de causalidad. Los bebedores más intensos difieren de los abstemios en dieta, peso y otros hábitos; el análisis ajustó por muchos de estos, pero no puede eliminarlos todos. El patrón específico por tipo (la cerveza la peor, el vino neutro) es coherente con el contenido de purinas de la cerveza más el alcohol.
Who this may not transfer to:A male-only cohort of health professionals. Women develop gout later and less often, largely after menopause; the direction of the alcohol link is thought to hold but was not measured here.
The study · 1
Choi et al., alcohol intake and risk of incident gout in men: a prospective study · Lancet 2004;363(9417):1277-81
Dos o más refrescos azucarados al día prácticamente duplicaron el riesgo de gota (RR 1.85)
Los hombres que bebían dos o más refrescos azucarados al día tenían casi el doble de riesgo de desarrollar gota, mientras que los refrescos light no conllevaban un riesgo adicional.
Los hombres que bebían dos o más refrescos azucarados al día tenían 1.85 veces el riesgo de gota nueva frente a menos de uno al mes (IC del 95 %: 1.08 a 3.16). El quintil más alto de ingesta de fructosa tenía aproximadamente el doble de riesgo que el más bajo (RR 2.02, 1.49 a 2.75). Los refrescos light no mostraron asociación. Measured in: 46,393 men in the Health Professionals Follow-up Study with no baseline gout, followed 12 years, with 755 incident cases. What could explain it instead: Higher sugary-drink intake tracks with higher body weight and total calorie intake, both of which raise gout risk on their own; adjustment reduces but does not eliminate this.. Una cohorte observacional que muestra asociación en lugar de causa. Que los refrescos light no conllevaran riesgo mientras que los azucarados sí apunta específicamente a la fructosa, que eleva el urato al acelerar la degradación de purinas, pero las personas que beben muchos refrescos azucarados también difieren en peso y dieta.
Who this may not transfer to:Male-only cohort. A companion analysis in women found a similar link between sugary drinks and gout, so the direction appears to transfer, but the numbers here are the men's.
The study · 1
Choi et al., soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study · BMJ 2008;336(7639):309-12
Más carne o marisco elevó el riesgo de gota entre un 40 % y un 50 %; las verduras ricas en purinas no lo hicieron
Comer más carne o marisco elevó el riesgo de desarrollar gota en aproximadamente un 40 % a un 50 %, mientras que las verduras ricas en purinas como las legumbres y las espinacas no conllevaron ningún riesgo.
Los hombres en el quintil más alto de ingesta de carne tenían 1.41 veces el riesgo de gota que el quintil más bajo (IC del 95 %: 1.07 a 1.86), y el quintil más alto de marisco 1.51 (1.17 a 1.95). Las verduras ricas en purinas no mostraron asociación (RR 0.96), y la proteína total no se vinculó con el riesgo. Measured in: 47,150 men in the Health Professionals Follow-up Study, 12 years, 730 incident cases. What could explain it instead: High meat and seafood eaters differ in weight and overall diet; adjustment addresses much but not all of this.. Observacional, por lo que hay asociación, no causa. El hallazgo importante es lo que está ausente: las plantas ricas en purinas que las viejas dietas para la gota prohibían (legumbres, guisantes, champiñones, espinacas) no conllevaron riesgo, lo que revierte un consejo de larga data.
Who this may not transfer to:Male-only cohort. The plant-purine finding (no risk) is mechanistically general and widely applied to women too, but was measured in men.
The study · 1
Choi et al., purine-rich foods, dairy and protein intake, and the risk of gout in men · N Engl J Med 2004;350(11):1093-103
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
El alopurinol llevó al 96 % al urato objetivo, frente a ninguno con placebo
En el único ensayo frente a una pastilla ficticia, el alopurinol llevó al 96 % de las personas a su nivel objetivo de ácido úrico frente a ninguno con placebo, que es cómo el tratamiento continuado disuelve los cristales y previene futuros ataques.
En el único ensayo controlado con placebo, el alopurinol llevó al 96 % de las personas (25 de 26) al urato sérico objetivo frente al 0 % (0 de 25) con placebo, un riesgo relativo de 49.11 (IC del 95 %: 3.15 a 765.58); el intervalo muy amplio refleja el pequeño ensayo. La revisión Cochrane completa cubrió 11 ensayos y 4531 participantes, pero la mayoría comparó al alopurinol con otros fármacos reductores de urato, no con placebo, y frente al febuxostat el alopurinol alcanzó el objetivo con menos frecuencia (RR 0.56; IC del 95 %: 0.48 a 0.65). La evidencia a corto plazo sobre la prevención de ataques agudos fue limitada, en parte porque los brotes pueden subir cuando se inicia la reducción de urato. Measured in: The placebo comparison rested on 1 trial with 57 participants; the wider Cochrane review pooled 11 randomized trials and 4,531 participants with chronic gout, mostly comparing allopurinol with other active urate-lowering drugs. La comparación con placebo es pequeña (57 personas), por lo que el efecto es cierto en dirección pero amplio en rango. Lo que es consistente en toda la evidencia es que el alopurinol reduce de forma fiable el urato al objetivo, el mecanismo por el cual el tratamiento sostenido disuelve los cristales y previene los ataques. Los ensayos a corto plazo capturan el período temprano cuando los brotes pueden aumentar temporalmente, por lo que subestiman el beneficio a más largo plazo que llega una vez que el nivel se mantiene bajo con cobertura de brotes durante los primeros meses.
Who this may not transfer to:Both sexes across the trials; allopurinol dosing is individualised and titrated to the target urate level, not fixed.
The study · 1
Seth et al., allopurinol for chronic gout · Cochrane Database Syst Rev 2014;(10):CD006077
La colchicina en dosis baja temprana alivió el dolor en el 38 % frente al 16 % con placebo, con mucha menos diarrea
Iniciada tempranamente en un brote, una dosis baja de colchicina alivió el dolor en aproximadamente el 38 % de las personas frente al 16 % con una pastilla ficticia, y funcionó igual de bien que la antigua dosis alta con mucha menos diarrea.
Para un brote agudo temprano, la colchicina en dosis baja (1.8 mg a lo largo de una hora) produjo al menos una reducción del 50 % en el dolor a las 24 horas en el 38 % de las personas, frente al 16 % con placebo. Igualó a la colchicina en dosis alta (4.8 mg a lo largo de seis horas) en el alivio del dolor mientras causaba mucha menos diarrea (23 % frente a 77 %). Measured in: 184 adults with an acute gout flare of no more than 12 hours' duration, randomized to low-dose colchicine, high-dose colchicine, or placebo. Esto prueba la colchicina iniciada muy temprano en un brote, dentro de las 12 horas, que es cuando funciona mejor; iniciada tarde es menos eficaz. La dosis baja y mejor tolerada funcionó igual de bien que la antigua dosis alta, la cual a menudo se abandonaba por sus efectos secundarios intestinales.
Who this may not transfer to:Both sexes; colchicine dosing is reduced in kidney impairment and with certain interacting drugs, so the dose is not universal.
The study · 1
Terkeltaub et al., high versus low dosing of oral colchicine for early acute gout flare (AGREE): a multicenter, randomized, double-blind, placebo-controlled trial · Arthritis Rheum 2010;62(4):1060-8
Una pérdida de peso importante redujo el ácido úrico en aproximadamente 1 a 3 mg/dL y redujo los ataques con el tiempo
Perder peso redujo el ácido úrico en sangre, en aproximadamente 1 a 3 puntos después de una pérdida de peso importante, y llevó a menos ataques de gota con el tiempo.
En 10 estudios longitudinales, la pérdida de peso se asoció con un menor urato sérico y, con el tiempo, una frecuencia reducida de ataques de gota. Las reducciones del urato sérico tras una pérdida de peso sustancial (en su mayoría bariátrica) oscilaron entre aproximadamente 1 y 3 mg/dL, y varios estudios reportaron menos brotes en el seguimiento. Los autores calificaron la certeza general como de baja a moderada. Measured in: Overweight and obese adults with gout or hyperuricemia across 10 longitudinal studies, most non-randomized and several involving bariatric surgery. La evidencia es de baja certeza: en su mayoría no aleatorizada, con métodos variados y sin una estimación de efecto combinada. Los ataques pueden subir transitoriamente en las primeras semanas tras una pérdida de peso rápida o una cirugía bariátrica, a medida que el urato movilizado cristaliza, antes de que la frecuencia baje, por lo que los panoramas a corto y largo plazo difieren.
Who this may not transfer to:A synthesis of heterogeneous studies, not a single cohort; the magnitude depends heavily on how much weight is lost and how (bariatric surgery drove the largest urate falls).
The study · 1
Nielsen et al., weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies · Ann Rheum Dis 2017;76(11):1870-1882
Más lácteos bajos en grasa significaron aproximadamente un 44 % menos de riesgo de gota
Los hombres que consumían más lácteos bajos en grasa, como leche desnatada y yogur, tenían aproximadamente un 44 % menos de riesgo de desarrollar gota.
Los hombres en el quintil más alto de ingesta de lácteos tenían 0.56 veces el riesgo de gota que el más bajo (IC del 95 %: 0.42 a 0.74), aproximadamente un 44 % menos de riesgo. El vínculo inverso estuvo impulsado por los lácteos bajos en grasa, como la leche desnatada y el yogur, no por los lácteos altos en grasa. Measured in: 47,150 men in the Health Professionals Follow-up Study, 12 years, 730 incident cases. What could explain it instead: Higher low-fat dairy intake correlates with a generally health-conscious diet and lower body weight, which independently lower gout risk.. Observacional. Las proteínas de la leche (caseína y lactalbúmina) parecen aumentar la excreción urinaria de urato, lo que le da a la asociación un mecanismo plausible, pero las personas que consumen más lácteos bajos en grasa también tienden a tener dietas más saludables en general.
Who this may not transfer to:Male-only cohort; the dairy mechanism (urate excretion) is not sex-specific but the figure is the men's.
The study · 1
Choi et al., purine-rich foods, dairy and protein intake, and the risk of gout in men · N Engl J Med 2004;350(11):1093-103
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Seis o más cafés al día significaron bastante menos de la mitad del riesgo de gota (RR 0.41)
Los hombres que bebían seis o más tazas de café al día tenían bastante menos de la mitad del riesgo de desarrollar gota; el descafeinado ayudó un poco y el té nada.
Los hombres que bebían seis o más tazas de café al día tenían 0.41 veces el riesgo de gota nueva frente a ninguna (IC del 95 %: 0.19 a 0.88), y de cuatro a cinco tazas 0.60 (0.41 a 0.87). El café descafeinado mostró un vínculo inverso más débil (RR 0.73 para cuatro o más tazas), y el té no mostró ninguno, lo que sugiere que el efecto no se debe solo a la cafeína. Measured in: 45,869 men in the Health Professionals Follow-up Study with no baseline gout, 12 years, 757 incident cases. What could explain it instead: Coffee intake correlates with smoking, alcohol and dietary patterns; the analysis adjusted for these, but residual confounding remains possible in any observational diet study.. Observacional. Que el descafeinado mostrara un efecto parcial y el té ninguno va en contra de la causalidad inversa y de que la cafeína sea la única causa, pero los grandes bebedores de café difieren en otros aspectos que el ajuste no puede captar por completo.
Who this may not transfer to:Male-only cohort. A separate analysis in women found a similar inverse link, so the direction appears to transfer.
The study · 1
Choi et al., coffee consumption and risk of incident gout in men: a prospective study · Arthritis Rheum 2007;56(6):2049-55
La mayor ingesta de vitamina C significó aproximadamente la mitad del riesgo de gota, un 17 % menos por cada 500 mg
Los hombres con la mayor ingesta de vitamina C tenían aproximadamente la mitad del riesgo de desarrollar gota, con el riesgo disminuyendo aproximadamente un 17 % por cada 500 mg adicionales al día.
Los hombres cuya ingesta total de vitamina C era de 1500 mg al día o más tenían 0.55 veces el riesgo de gota nueva frente a menos de 250 mg (IC del 95 %: 0.38 a 0.80). El riesgo disminuía aproximadamente un 17 % por cada 500 mg adicionales al día de ingesta. Measured in: 46,994 men in the Health Professionals Follow-up Study with no baseline gout, followed 20 years, with 1,317 incident cases. What could explain it instead: People taking high-dose vitamin C supplements are more health-conscious on average (diet, weight, activity), which independently lowers gout risk.. Observacional, mostrando asociación, no causa. La vitamina C aumenta la excreción urinaria de urato, lo que respalda el vínculo, pero el grupo de mayor ingesta alcanzó ese nivel en gran parte mediante suplementos y tiende a diferir en el comportamiento de salud.
Who this may not transfer to:Male-only cohort; the urate-excretion mechanism is not sex-specific but the figure is the men's.
The study · 1
Choi et al., vitamin C intake and the risk of gout in men: a prospective study · Arch Intern Med 2009;169(5):502-7
Los suplementos de vitamina C redujeron el ácido úrico en aproximadamente 0.35 mg/dL
Los suplementos de vitamina C redujeron el ácido úrico en sangre en una pequeña cantidad, aproximadamente 0.35 puntos, mucho menos de lo que logra un medicamento para la gota.
Al combinar 13 ensayos aleatorizados, la suplementación con vitamina C redujo el ácido úrico sérico en 0.35 mg/dL (IC del 95 %: -0.66 a -0.03) frente al control. La dosis mediana fue de 500 mg al día y la duración mediana del ensayo de 30 días. Measured in: 556 participants across 13 randomized controlled trials, mostly in people without gout. La caída es pequeña, aproximadamente 0.35 mg/dL, mucho menos de lo que aporta un fármaco reductor de urato, y los ensayos fueron cortos y en su mayoría en personas sin gota. Reducir el nivel promedio no es lo mismo que prevenir los brotes, y un ensayo posterior en pacientes con gota encontró poco efecto sobre el urato, por lo que la vitamina C se interpreta mejor como una ayuda menor, no un tratamiento.
Who this may not transfer to:Both sexes across the trials, but most participants did not have gout, so the finding is about the urate level in general, not about flare prevention in people who already have gout.
The study · 1
Juraschek et al., effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials · Arthritis Care Res (Hoboken) 2011;63(9):1295-306
La DASH redujo el ácido úrico 0.35 mg/dL en promedio, 1.29 en quienes comenzaron más alto
El patrón alimentario DASH redujo el ácido úrico en una pequeña cantidad en promedio, pero en una cantidad mucho mayor en las personas que partían de los niveles más altos.
En un ensayo de alimentación controlada, la dieta DASH redujo el ácido úrico sérico en 0.35 mg/dL frente a una dieta control típica (IC del 95 %: -0.65 a -0.05). Entre los participantes que comenzaron con el urato más alto (7 mg/dL o más), bajó 1.29 mg/dL. Una mayor ingesta de sodio tuvo el efecto opuesto, más pequeño, bajando ligeramente el urato. Measured in: 103 adults with above-optimal blood pressure in a secondary analysis of the DASH-Sodium controlled feeding trial, fed each diet under supervision. Este es un análisis secundario de un ensayo diseñado para la presión arterial, en personas con presión arterial elevada, no gota, y toda la comida se suministró bajo condiciones controladas, lo cual es más de lo que una persona logra en casa. La mayor caída en quienes comenzaron más alto es la cifra más relevante clínicamente.
Who this may not transfer to:Both sexes, but selected for raised blood pressure, not gout; the urate effect is expected to transfer to people with gout, especially those starting with a high level.
The study · 1
Juraschek et al., effects of the Dietary Approaches to Stop Hypertension (DASH) diet and sodium intake on serum uric acid · Arthritis Rheumatol 2016;68(12):3002-3009
Comer más cercano a la DASH significó aproximadamente un 32 % menos de riesgo de gota
Los hombres cuya alimentación más se asemejaba al patrón DASH tuvieron aproximadamente un tercio menos de riesgo de desarrollar gota, mientras que una dieta más occidental lo elevó.
Los hombres cuya alimentación coincidía más estrechamente con un patrón DASH tuvieron 0.68 veces el riesgo de gota nueva frente a quienes coincidían menos (IC del 95 %: 0.57 a 0.80), aproximadamente un 32 % menos de riesgo. Quienes comían un patrón más occidental (carne roja y procesada, azúcar, granos refinados) tuvieron 1.42 veces el riesgo (1.16 a 1.74). Measured in: 44,444 men in the Health Professionals Follow-up Study with no baseline gout, followed 26 years, with 1,731 incident cases. What could explain it instead: A high DASH score tracks with lower body weight, more activity and less alcohol, each of which independently lowers gout risk; adjustment reduces but does not remove this overlap.. Observacional, mostrando asociación, no causa, aunque se alinea con el ensayo de alimentación que midió el urato directamente bajo condiciones controladas. Las puntuaciones de patrón dietético capturan hábitos alimentarios amplios que acompañan al peso, la actividad y otros comportamientos.
Who this may not transfer to:Male-only cohort; the pattern is consistent with the mixed-sex DASH feeding trial, which supports transfer to women.
The study · 1
Rai et al., the DASH diet, Western diet, and risk of gout in men: prospective cohort study · BMJ 2017;357:j1794
Comer cerezas se vinculó con aproximadamente un 35 % menos de probabilidades de un ataque de gota
Comer cerezas durante un par de días se vinculó con aproximadamente un 35 % menos de probabilidades de un ataque de gota en esa ventana, y todavía menos cuando se combinaba con alopurinol.
Comer cerezas durante un período de dos días se asoció con 0.65 veces las probabilidades de un ataque de gota en esa ventana frente a ninguna ingesta (IC del 95 %: 0.50 a 0.85), aproximadamente un 35 % menos de probabilidades. Las cerezas tomadas junto con alopurinol se asociaron con 0.25 veces las probabilidades. Measured in: 633 people with gout recruited online, contributing 1,247 attacks over one year, each comparing exposure in the two days before an attack against their own attack-free periods. What could explain it instead: People may eat cherries precisely when they sense an attack coming, or change other habits at the same time, either of which could bias the within-person comparison.. Un diseño de caso cruzado compara a cada persona consigo misma, lo que elimina las diferencias estables entre personas, pero no puede descartar que algo más cambiara junto con la ingesta de cerezas en esos dos días. La dieta fue autoinformada por una cohorte en línea, y el diseño no puede establecer causalidad. El efecto es modesto y no está confirmado por un ensayo aleatorizado.
Who this may not transfer to:Both sexes, self-selected online cohort with established gout; generalisability to a first-time or milder presentation is uncertain.
The study · 1
Zhang et al., cherry consumption and decreased risk of recurrent gout attacks · Arthritis Rheum 2012;64(12):4004-11
Un polvo de leche descremada enriquecido redujo la frecuencia de brotes de gota más que un polvo ficticio
Un polvo de leche descremada especialmente enriquecido redujo la frecuencia de los brotes de gota, más que un polvo ficticio, aunque todos los grupos mejoraron algo.
A lo largo de tres meses, los brotes de gota autoinformados bajaron en los tres grupos. La mayor caída fue en el grupo que tomaba polvo de leche descremada enriquecido con glucomacropéptido y un extracto de grasa láctea (G600), que tuvo una reducción significativamente mayor en la frecuencia de brotes que el control de polvo de lactosa. Measured in: 120 people with recurrent gout in a three-arm, three-month proof-of-concept randomized trial comparing enriched skim milk powder, standard skim milk powder, and a lactose control powder. Un ensayo pequeño, corto, de prueba de concepto con brotes autoinformados, y se observa una respuesta placebo en que los tres grupos mejoraron. Prueba un producto lácteo enriquecido específico, no lácteos ordinarios, por lo que respalda la señal de los lácteos sin demostrar un efecto de la leche simple sobre los brotes.
Who this may not transfer to:Both sexes with established recurrent gout; the product tested is not ordinary supermarket milk, so read it as support for the dairy direction, not a dosing instruction.
The study · 1
Dalbeth et al., effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial · Ann Rheum Dis 2012;71(6):929-34
What Diet Alone Can and Cannot Do
The diet levers are worth doing, and each has a mechanism behind it, but their effect on the level is small. The DASH pattern lowered uric acid by about 0.35 mg/dL on average in a controlled feeding trial, reaching 1.29 mg/dL in the people who started highest. Vitamin C supplements lowered it by a similar 0.35 mg/dL across 13 trials, a small drop not shown to cut the flares themselves. A daily urate-lowering tablet, by contrast, brings almost everyone to the target. So for a first flare, a raised level with no symptoms, or general risk reduction, diet is a sensible and sufficient first move. For recurrent attacks or tophi, it helps but rarely gets the level low enough alone. The tablet clears the crystals diet leaves behind, so at that stage relying on diet alone keeps the flares coming.
One old piece of diet advice is wrong and can be dropped. Beans, lentils, peas, mushrooms and spinach were banned from gout diets for generations because they contain purines. In the cohort of 47,150 men, these purine-rich vegetables carried no increased risk at all, and total protein was not linked either. The purines that matter come from meat and seafood, the foods that did raise risk, plus alcohol and fructose. A purine-free crash diet is neither necessary nor effective.
Eating cherries over a two-day window was linked to about 35% lower odds of a flare, in a study of 633 people. The odds fell further alongside allopurinol, though the design cannot prove cause.
What To Do First
Start with the drinks, they move the level most for the least effort. Treat a rising level or returning attacks as the signal to add the tablet.
These are the biggest daily levers on the level. Swap the beer, spirits and sugary soft drinks for coffee and water, and keep wine, if any, moderate.
Skim milk and yogurt help the kidneys pass urate. Build meals on vegetables, fruit, whole grains and low-fat dairy, with less red meat and sugar.
Beans, lentils, mushrooms and spinach were wrongly banned for their purines and carry no gout risk. The purines that matter come from meat, seafood, alcohol and sugary drinks.
This is the most powerful lever, and the hardest to hold. Go steady, because attacks can briefly rise in the weeks right after rapid loss before they fall.
You can order a serum uric-acid test yourself through direct-to-consumer testing and re-check it as you change things. Watch it fall toward the target that keeps crystals from forming.
Returning attacks, tophi you can feel, or a level that stays high are the point where a daily urate-lowering tablet is usually worth it. Take that decision to your prescriber.
Go Deeper
- Weight and metabolic health: the biggest single lever on the uric-acid level.
- The DASH diet and cutting sodium: the vegetable-and-dairy eating pattern that nudges the level down.
- Alcohol: where beer and spirits sit against wine for gout and wider health.
- Coffee and caffeine: the drink tied to lower gout risk.
- Vitamin C: the supplement that trims the level a little.
- Kidney stones: the uric-acid stones that share gout's cause, and how water helps both.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine reads gout as a form of Bi syndrome (痹证), an obstruction of qi and blood in the joints, and names the burning-hot swollen version Damp-Heat pooling in the channels. The old texts blamed rich, fatty, sweet food and alcohol for breeding damp-heat that settles in the joints, a list that resembles the modern dietary triggers above. The overlap is a curiosity of two very different systems landing on similar dietary suspects, not evidence that the classical diagnosis was tracking uric acid. In two situations a practitioner strengthens and circulates the body as well as cooling it. Many long-standing patients have an underlying Spleen and Kidney weakness that cannot transform fluids, and the chalky tophi of chronic gout are read as phlegm-damp congealed with blood stasis. The cooling, damp-draining herbs are the wrong direction for someone cold, pale, loose in the bowels and depleted.
The acute flare: a joint that is red, hot, swollen and severely painful, often the big toe or foot, worse for heat and pressure, with a red tongue and a greasy yellow coat. The direction is to clear heat, drain damp and unblock the channel.
Chronic gout with hard lumps (tophi), a dusky or fixed ache, and deformity building over years. The direction is to transform phlegm, move blood and dissolve the accumulation.
The underlying terrain in many recurrent cases: fatigue, poor digestion, loose stools, low back and knee weakness, a pale swollen tongue. The direction is to strengthen the Spleen and support the Kidneys so the body transforms damp instead of letting it pool.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Do not stop your urate-lowering tablet during a flare
If you already take allopurinol or another urate-lowering drug, keep taking it through an attack. Stopping and restarting swings the uric-acid level, and those swings can set off more flares. Treat the flare with the anti-inflammatory, colchicine or steroid you were given, and leave the daily tablet running. Starting a urate-lowering tablet for the first time is timed with your prescriber, with flare cover for the first months.
Allopurinol hypersensitivity and the HLA-B*5801 gene
Allopurinol rarely triggers a severe hypersensitivity reaction that starts as a spreading rash and can progress to blistering and peeling skin. The risk is strongly linked to the HLA-B*5801 gene variant. It is far more common in people of Han Chinese, Korean and Thai ancestry. Testing before starting allopurinol is recommended for those groups. Starting at a low dose and raising it slowly also lowers the risk. A widespread rash, blistering, facial swelling or peeling skin after starting the drug means stopping it and seeking care the same day.
Match the acute treatment to your kidneys and other drugs
The three flare treatments are not interchangeable for everyone. Anti-inflammatory painkillers such as ibuprofen and naproxen are avoided in kidney disease and with stomach ulcers. Colchicine is reduced or avoided in kidney impairment and with certain interacting drugs, since it can build up to toxic levels. A short course of an oral steroid is often the safer choice when the other two do not fit. This is a question of which one suits you, agreed with your prescriber before an attack where possible.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
When to See Someone
Most of managing gout is steady and in your own hands. A few situations need medical attention quickly. These are the signs to get seen about:
- A hot, swollen, very painful joint with fever, chills, or feeling generally unwell. This can be a joint infection (septic arthritis), it must be drained and treated within days to save the joint(seek urgent care)
- A first-ever attack that involves several joints at once, a large joint such as the knee or shoulder, or a high fever. That is not the usual gout pattern and needs assessment(seek urgent care)
- New rash, blistering, facial swelling or peeling skin after starting allopurinol or another urate-lowering drug: stop the drug and seek care the same day(seek urgent care)
- Severe one-sided flank or back pain, or blood in the urine: signs of a possible uric-acid kidney stone
- A gout attack that is not settling after several days of the treatment you were given, or that keeps returning within weeks
- Known kidney disease, or a first attack under 40: both affect which flare drugs are safe, so mention them before starting one
The DASH-style plate and steady weight loss are largely in your hands, and allopurinol is added only when attacks keep returning.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 14 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.